Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3375 | 30.07 | 4142922 | |
ZYME | Zymeworks Inc. Common Stock | Healthcare | Biotechnology | 890 | 12.79 | 595099 |
Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 14 | RSI Threshold: | 0 | ||
Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | -1274.19 |
Total net P/L: | -11274.19 | Total ROI: | -112.74 % |
CAGR: | 0.00 % | Max. DD: | 109.65 % |
System Score: | 0.000 | Sharpe Ratio: | 0.581 |
Start Date: | 2020-01-02 | End Date: | 2025-02-28 |
Total days: | 1884 | ||
Commissions: | 558.20 | Comm.% P/L | 5.21 % |
Total Transactions: | 180 | Log. Linearity: | 77.919 % |
Total | ![]() |
![]() |
VKTX | ZYME | |
---|---|---|---|---|---|
Total Profit/Loss | -10715.99 | 221.77 | -10937.76 | -10238.66 | -477.33 |
Total Profit | 10518.41 | 5056.29 | 5462.12 | 7708.14 | 11305.57 |
Total Loss | 21234.40 | 4834.52 | 16399.88 | 17946.80 | 11782.90 |
Profit Factor | 0.50 | 1.05 | 0.33 | 0.43 | 0.96 |
Trades | 45 | 17 | 28 | 45 | 45 |
Winning Trades | 32 | 13 | 19 | 20 | 31 |
Losing Trades | 13 | 4 | 9 | 24 | 14 |
% Profitable | 71.00 | 76.00 | 67.00 | 44.00 | 68.00 |
Profit/Loss Per Trade % | 0.00 | 1.04 | 0.00 | 0.00 | 0.26 |
Profit Per Trade % | 7.59 | 8.41 | 7.03 | 7.89 | 8.92 |
Loss Per Trade % | 26.41 | 17.07 | 30.79 | 12.71 | 14.98 |
Days In Trade | 507 | 168 | 339 | 507 | 507 |
Days In Trade (Avg. Per Trade) | 11.27 | 9.88 | 12.11 | 11.27 | 11.27 |
% Days In Trade | 26.91 | 8.92 | 17.99 | 26.91 | 26.91 |